Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses

Bibliographic Details
Main Authors: Jeswin Joseph, T. Karthika, V.R. Akshay Das, V. Stalin Raj
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:Journal of Global Antimicrobial Resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716521001338